Drug Identity
Active Ingredient
Irinotecan
Drug Class
Antineoplastics
ATC Code
L01CE02
Status
Essential Medicine
What is RINOCN?
Uses
Monjuvi is used to treat diffuse large B-cell lymphoma (DLBCL ) in combination with lenalidomide that is relapsed or refractory (r/r), or...
How It Works
Administer by IV Infusion, usually over 90 min. D5W (500 ml) is the preferred diluent for most doses. Solutions diluted in NS may precipitate if refrigerated. Dilute in D5W or NS to a final cons of 0.122.8 mg/ml. Due to the relatively acidic pH, irinotecan appears to be more stable in D5W than NS, D5W (500 ml) is the preferred diluent for most doses.
How to Take It
Dosage information not available for this product.
Safety Alerts
Chronic inflammatory bowel disease, bowel obstruction, hepatic impairment, renal impairment, severe myelosuppression
Important Warnings
Monjuvi may cause the following serious side effects: Infusion reactions
Your healthcare provider will monitor you for infusion reactions during your infusion of Monjuvi
Tell your healthcare provider right away if you get a fever, chills, rash, flushing, headache, or shortness of breath during an infusion of Monjuvi
Low blood cell counts (platelets, red blood cells, and white blood cells)
Low blood cell counts are common with Monjuvi, but can also be serious or severe
Your healthcare provider will monitor your blood counts during treatment with Monjuvi
Tell your healthcare provider right away if you get a fever of 100
4°F (38°C) or above, or any bruising or bleeding, or fever, mouth sores, skin sores, sore throat , cough, trouble breathing
Side Effects
Interstitial pulmonary diseaseacute cholinergic syndrome and delayed diarrhoea (consult product literature)alopeciaanorexiaastheniabone-marrow suppressionextravasationGI effectshyperuricaemiamyelosuppression(dose limiting)nauseaoral mucositisthromboembolismtumourlysis syndromevomiting
Drug Interactions
Neuromuscular blocking agents
carbamazepine
phenobarbital
phenytoin
ketoconazole
Pregnancy & Lactation
Pregnancy
Positive evidence of risk: Avoid
Lactation
Contraindicated. Discontinue breast-feeding
Price Intelligence
Rs 12,537.56
DRAP approved maximum price · per unit · approved 19 Aug, 2025
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
No retail prices recorded
Should you consider an alternative?
Other options containing Irinotecan, and what they are not.
Identical active ingredient at the same strength. Cheapest per unit first.
Campto
100mg
Rs 26,303.37
Pfizer Pakistan Limited DSL: 687
IRO ONKO
100mg
Rs 13,833.19 ceiling
No DRAP alertsPUNJAB MEDICAL SERVICES
Cytotecan
100mg
Rs 20,653.05 ceiling
No DRAP alertsCCL Pharmaceuticals (Pvt.) Ltd.
Ordered by lowest price per unit where a pack size is known, then by price. Order is never affected by sponsorship. Not medical advice — confirm any change with your pharmacist or doctor.
For pharma professionalsCompany, market and opportunity intelligence
Company
24
brands
37
molecules
0
alerts